Hudson Bay Capital Management »

Contineum Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $297k 26k 11.43

More positions owned by Hudson Bay Capital Management

Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Palantir Technologies Cl A Put Option (PLTR)
Microsoft Corporation Call Option (MSFT)
Netflix Put Option (NFLX)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Flagstar Bank National Assoc Com New (FLG)
Dollar Tree Call Option (DLTR)
Boeing Company Call Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Contineum Therapeutics

Suvretta Capital Management
RA Capital Management
Johnson & Johnson
Franklin Resources
Vanguard Group
Balyasny Asset Management
Commodore Capital
FMR
Sectoral Asset Management
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management

View all funds holding Contineum Therapeutics